The first printing of the USP (United States Pharmacopoeia) occurred over 200 years ago, in 1820. The goal was simple: Ensure public safety and build trust by establishing quality standards for medicines, additives, and food.
USP <661> “Plastic Packaging Systems and Their Materials of Construction” establishes testing standards and parameters for the thermoplastic resins used in manufacturing containers and packaging to store medicines and pharmacopeial articles.
While other plastics are listed in USP <661>, the main thermoplastic resins include Low-Density Polyethylene (LDPE), High-Density Polyethylene (HDPE), Polypropylene (PP), Polyethylene Terephthalate (PET), and a thermoplastic polyester — Polyethylene Terephthalate Glycol (PETG).
As an FDA-registered, cGMP-compliant, and ISO/IEC 17025-accredited pharmaceutical testing laboratory, BA Sciences brings over 25 years of experience in repeatable and reliable raw materials identity testing and validation.
The thoroughness, accuracy, and repeatability of BA Sciences testing help customers become cGMP and FDA-compliant by adhering to the stringent regulatory requirements found in USP <661>.